Canada’s Drug Agency | Drugs, Health Technologies and Systems.

Urothelial carcinoma

Details

Review Type: Rapid

Provisional Funding Algorithm
Draft Report Posted: Feb 13, 2025
Feedback Deadline: Feb 21, 2025
Final Report Posted: Apr 1, 2025

 

Last Updated : April 1, 2025

Myelofibrosis

Details

Review Type: Rapid

Provisional Funding Algorithm
Draft Report Posted: Feb 13, 2025
Feedback Deadline: Feb 21, 2025
Final Report Posted : Apr 4, 2025

 

Last Updated : April 4, 2025